The global thoracic catheters market size was estimated at USD 462.33 million in 2024 and is projected to reach USD 748.91 million by 2033, growing at a CAGR of 5.60% from 2025 to 2033. The industry is primarily driven by the rising prevalence of respiratory and thoracic diseases, such as pleural effusion, pneumothorax, Hemothorax, Empyema, and lung cancer, which require adequate drainage and postoperative management.
The increasing number of thoracic and pulmonary surgeries, including minimally invasive and robotic-assisted procedures, has driven up the demand for advanced catheter systems to ensure efficient fluid evacuation and promote patient recovery. According to data published by the UK Health Security Agency and the Centre for Climate and Health Security in August 2025, asthma is prevalent in the UK, with 7.2 million people suffering from the condition.
The increasing prevalence of respiratory and thoracic conditions such as pleural effusion, pneumothorax, lung cancer, chronic obstructive pulmonary disease, and post-surgical complications is a primary factor driving the thoracic catheter market. These conditions often lead to the accumulation of air or fluid in the pleural cavity, necessitating the use of thoracic catheters for drainage and respiratory support. The global rise in smoking rates, air pollution, and lifestyle-related lung disorders has further contributed to the growing number of thoracic interventions. As more patients require effective and minimally invasive solutions for pleural management, the demand for advanced catheters with improved safety, comfort, and infection control continues to increase. This trend is expected to sustain strong market growth, particularly in hospitals and critical care units that frequently manage complex thoracic and pulmonary cases.
The rising incidence of empyema cases is boosting the demand for advanced, infection-resistant thoracic catheter systems in hospitals and critical care settings. In December 2024, the National Center for Biotechnology Information (NCBI) reported that pleural infections, including empyema and complicated parapneumonic effusion, pose a significant health burden, affecting approximately 80,000 patients annually across the U.S. and the UK.
The increasing number of thoracic surgeries and the growing adoption of minimally invasive procedures drive the thoracic catheter market. The rising incidence of lung cancer, mediastinal tumors, and other thoracic disorders has led to a surge in surgical interventions, requiring efficient postoperative drainage and fluid management. Minimally invasive techniques such as video-assisted thoracoscopic surgery and robotic-assisted thoracic surgeries are becoming more prevalent due to their advantages of reduced trauma, faster recovery, and shorter hospital stays. These procedures often necessitate advanced thoracic catheters compatible with smaller incisions, providing adequate drainage with minimal patient discomfort. As surgical volumes continue to increase, particularly in specialized centers and high-capacity hospitals, the demand for innovative and patient-friendly catheter systems is expected to grow, strengthening market expansion. According to Shanghai Chest Hospital in 2021, the percentage of Minimally Invasive Surgery was 92.7%, with 1,006 robotic-assisted thoracic surgeries.
Technological innovations play a pivotal role in driving the growth of the thoracic catheter industry by enhancing the safety, efficiency, and comfort of thoracic drainage procedures. Advances like developing small-bore and soft-tipped catheters, antimicrobial coatings, and biocompatible materials have significantly reduced the risk of infection and patient discomfort. Integrating drainage systems with digital monitoring, one-way valves, and portable collection devices allows for more precise fluid management and supports outpatient or home-based care. Furthermore, using image-guided and ultrasound-assisted catheter placement techniques has improved procedural accuracy and reduced complications. These continuous innovations expand the clinical applications of thoracic catheters and encourage wider adoption across hospitals and ambulatory settings, accelerating market growth.
This product will be delivered within 1-3 business days.
The increasing number of thoracic and pulmonary surgeries, including minimally invasive and robotic-assisted procedures, has driven up the demand for advanced catheter systems to ensure efficient fluid evacuation and promote patient recovery. According to data published by the UK Health Security Agency and the Centre for Climate and Health Security in August 2025, asthma is prevalent in the UK, with 7.2 million people suffering from the condition.
The increasing prevalence of respiratory and thoracic conditions such as pleural effusion, pneumothorax, lung cancer, chronic obstructive pulmonary disease, and post-surgical complications is a primary factor driving the thoracic catheter market. These conditions often lead to the accumulation of air or fluid in the pleural cavity, necessitating the use of thoracic catheters for drainage and respiratory support. The global rise in smoking rates, air pollution, and lifestyle-related lung disorders has further contributed to the growing number of thoracic interventions. As more patients require effective and minimally invasive solutions for pleural management, the demand for advanced catheters with improved safety, comfort, and infection control continues to increase. This trend is expected to sustain strong market growth, particularly in hospitals and critical care units that frequently manage complex thoracic and pulmonary cases.
The rising incidence of empyema cases is boosting the demand for advanced, infection-resistant thoracic catheter systems in hospitals and critical care settings. In December 2024, the National Center for Biotechnology Information (NCBI) reported that pleural infections, including empyema and complicated parapneumonic effusion, pose a significant health burden, affecting approximately 80,000 patients annually across the U.S. and the UK.
The increasing number of thoracic surgeries and the growing adoption of minimally invasive procedures drive the thoracic catheter market. The rising incidence of lung cancer, mediastinal tumors, and other thoracic disorders has led to a surge in surgical interventions, requiring efficient postoperative drainage and fluid management. Minimally invasive techniques such as video-assisted thoracoscopic surgery and robotic-assisted thoracic surgeries are becoming more prevalent due to their advantages of reduced trauma, faster recovery, and shorter hospital stays. These procedures often necessitate advanced thoracic catheters compatible with smaller incisions, providing adequate drainage with minimal patient discomfort. As surgical volumes continue to increase, particularly in specialized centers and high-capacity hospitals, the demand for innovative and patient-friendly catheter systems is expected to grow, strengthening market expansion. According to Shanghai Chest Hospital in 2021, the percentage of Minimally Invasive Surgery was 92.7%, with 1,006 robotic-assisted thoracic surgeries.
Technological innovations play a pivotal role in driving the growth of the thoracic catheter industry by enhancing the safety, efficiency, and comfort of thoracic drainage procedures. Advances like developing small-bore and soft-tipped catheters, antimicrobial coatings, and biocompatible materials have significantly reduced the risk of infection and patient discomfort. Integrating drainage systems with digital monitoring, one-way valves, and portable collection devices allows for more precise fluid management and supports outpatient or home-based care. Furthermore, using image-guided and ultrasound-assisted catheter placement techniques has improved procedural accuracy and reduced complications. These continuous innovations expand the clinical applications of thoracic catheters and encourage wider adoption across hospitals and ambulatory settings, accelerating market growth.
Global Thoracic Catheter Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global thoracic catheter market report on the basis of product, material, application, end-use, and region:Product Outlook (Revenue, USD Million, 2021-2033)
- Thoracostomy Tubes
- Pleural Drainage Catheters
- Others
Material Outlook (Revenue, USD Million, 2021-2033)
- Silicone
- Polyurethane
- PVC
- Others
Application Outlook (Revenue, USD Million, 2021-2033)
- Pneumothorax
- Pleural Effusion
- Hemothorax
- Others
End-use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers (ASCs)
- Others
Regional Outlook (Revenue, USD Million, 2021-2033)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa (MEA)
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Thoracic Catheter Market Variables, Trends & Scope
Chapter 4. Thoracic Catheter Market: Material Estimates & Trend Analysis
Chapter 5. Thoracic Catheter Market: Product Estimates & Trend Analysis
Chapter 6. Thoracic Catheter Market: Application Estimates & Trend Analysis
Chapter 7. Thoracic Catheter Market: End Use Estimates & Trend Analysis
Chapter 8. Thoracic Catheter Market: Regional Estimates & Trend Analysis by Material, Product, Application, End Use, and Region
Chapter 9. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The key companies profiled in this Thoracic Catheters market report include:- Teleflex Incorporated
- Smiths Medical (ICU Medical, Inc.)
- B. Braun Melsungen AG
- Vygon SA
- Cook Medical
- Terumo Corporation
- Nipro Corporation
- Asahi Kasei Corporation
- Becton, Dickinson and Company
- Dongguan Jiajie Medical Tech Co., Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | November 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 462.33 Million |
| Forecasted Market Value ( USD | $ 748.91 Million |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
